Neurotherapeutics Across Blood–Brain Barrier: Screening of BBB-Permeable and CNS-Active Molecules for Neurodegenerative Disease

Tox21 https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1616144/full 2025-09-25T00:00:00Z Frontiers in Pharmacology